Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236 SEK | -0.34% |
|
+7.66% | -11.87% |
12/07 | BioArctic Partnership Secures Israeli Approval for Alzheimer's Disease Treatment Leqembi | MT |
11/07 | Global markets live: Tesla, Citigroup, BP, Novo Nordisk, JPMorgan... | ![]() |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.87% | 197.01Cr | |
+22.15% | 4.66TCr | |
+45.94% | 4.17TCr | |
-2.37% | 4.12TCr | |
+33.84% | 3.24TCr | |
-6.35% | 2.81TCr | |
+20.42% | 2.82TCr | |
+48.83% | 1.45TCr | |
+45.00% | 1.37TCr | |
+0.06% | 1.22TCr |
- Stock Market
- Equities
- BIOA B Stock
- News BioArctic AB
- BioArctic, Eisai's Alzheimer's Disease Drug Wins Regulatory Nod in Hong Kong